Transcriptomic profiling reveals conserved stage‐associated programs across gastrointestinal adenocarcinomas
- 1Department of Biological Engineering, School of Chemical, Biological and Materials Engineering and Sciences Mapúa University Manila City Philippines
- 2Department of Food Science National Taiwan Ocean University Keelung Taiwan
- 3Department of Biology, School of Health Sciences Mapúa University Makati City Philippines
Abstract
Background Gastrointestinal (GI) adenocarcinomas exhibit substantial molecular heterogeneity despite their shared epithelial origin and anatomical continuity. Whether these anatomically distinct cancers share conserved transcriptomic programs associated with pathological stage remains unclear. Aims This study aimed to identify conserved transcriptomic programs associated with pathological stage across pan‐GI adenocarcinomas using an integrated transcriptomic network analysis approach. Methods and results RNA sequencing data from oesophageal, gastric, colon and rectal adenocarcinomas in The Cancer Genome Atlas were integrated into a stage‐stratified pan‐GI cohort. Weighted gene co‐expression network analysis identified conserved co‐expression modules, which were validated through hub gene validation in independent Clinical Proteomic Tumor Analysis Consortium Phase cohorts and module preservation analysis in Gene Expression Omnibus datasets. Functional enrichment, differential expression, miRNA–mRNA regulatory network and survival analyses were subsequently performed. Two conserved co‐expression modules remained significantly associated with pathological stage after adjustment for age, sex and primary anatomical site. These modules were enriched for intracellular signalling and extracellular matrix‐related pathways and contained seven consistently dysregulated validated hub genes (ZEB1, FERMT2, MPDZ, LRCH2, ZFPM2, GLI3 and PDGFRB), together with three candidate regulatory microRNAs (hsa‐miR‐19a, hsa‐miR‐19b and hsa‐miR‐20a). Conclusion Pan‐GI transcriptomic profiling identified conserved epithelial‐ and stromal‐associated molecular programs shared across anatomically distinct GI adenocarcinomas. These reproducible transcriptomic features provide a systems‐level framework for understanding shared disease biology and establish a foundation for future mechanistic studies and stage‐informed therapeutic strategies.
Related
- Integration of Transcriptomic and Metabolomic Profiling as a Source of Insight into Key Candidate Genes and Metabolic Pathways Associated with Maize Resistance to Fusarium spp.
- Comparative Transcriptomic and Physiological Profiling Reveals Species-Associated Differences Across Five Duckweed Species
- Tissue-resolved transcriptomic and proteomic profiling reveals organ-specific molecular signatures associated with inter-animal variation in glycemic response to metformin in obese diabetic Mongolian gerbils
- JuxtaBAM: a species and SNP-independent method to validate the integrity of joint epigenomic and transcriptomic profiling datasets
- Impaired Brain Astrocytic Glycolysis in Neuropathic Pain: Insights from Transcriptomic Profiling to Metabolic Intervention
BibTeX
@article{abenojar2026transcriptomic,
title = {{Transcriptomic profiling reveals conserved stage‐associated programs across gastrointestinal adenocarcinomas}},
author = {Wynston Jay Abenojar and Ron Jacob Avila and Po‐Wei Tsai and Lemmuel Tayo},
journal = {Clinical and Translational Discovery},
year = {2026},
month = oct,
doi = {10.1002/ctd2.70201},
url = {https://doi.org/10.1002/ctd2.70201},
note = {CC BY},
}
RIS
TY - JOUR
TI - Transcriptomic profiling reveals conserved stage‐associated programs across gastrointestinal adenocarcinomas
AU - Wynston Jay Abenojar
AU - Ron Jacob Avila
AU - Po‐Wei Tsai
AU - Lemmuel Tayo
PY - 2026
DA - 2026/10/26
JO - Clinical and Translational Discovery
DO - 10.1002/ctd2.70201
UR - https://doi.org/10.1002/ctd2.70201
AB - Background Gastrointestinal (GI) adenocarcinomas exhibit substantial molecular heterogeneity despite their shared epithelial origin and anatomical continuity. Whether these anatomically distinct cancers share conserved transcriptomic programs associated with pathological stage remains unclear. Aims This study aimed to identify conserved transcriptomic programs associated with pathological stage across pan‐GI adenocarcinomas using an integrated transcriptomic network analysis approach. Methods and results RNA sequencing data from oesophageal, gastric, colon and rectal adenocarcinomas in The Cancer Genome Atlas were integrated into a stage‐stratified pan‐GI cohort. Weighted gene co‐expression network analysis identified conserved co‐expression modules, which were validated through hub gene validation in independent Clinical Proteomic Tumor Analysis Consortium Phase cohorts and module preservation analysis in Gene Expression Omnibus datasets. Functional enrichment, differential expression, miRNA–mRNA regulatory network and survival analyses were subsequently performed. Two conserved co‐expression modules remained significantly associated with pathological stage after adjustment for age, sex and primary anatomical site. These modules were enriched for intracellular signalling and extracellular matrix‐related pathways and contained seven consistently dysregulated validated hub genes (ZEB1, FERMT2, MPDZ, LRCH2, ZFPM2, GLI3 and PDGFRB), together with three candidate regulatory microRNAs (hsa‐miR‐19a, hsa‐miR‐19b and hsa‐miR‐20a). Conclusion Pan‐GI transcriptomic profiling identified conserved epithelial‐ and stromal‐associated molecular programs shared across anatomically distinct GI adenocarcinomas. These reproducible transcriptomic features provide a systems‐level framework for understanding shared disease biology and establish a foundation for future mechanistic studies and stage‐informed therapeutic strategies.
SN - 2768-0622
ER -